Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 149

Cited In for PubMed (Select 20488523)


Antituberculosis Drug Resistance Survey in Lesotho, 2008-2009: Lessons Learned.

Maama-Maime LB, Mareka M, Ershova JV, Tlali TE, Kao K, Phalatse M, Polansky L, Beres LK, Letsie M, Holtz TH.

PLoS One. 2015 Jul 24;10(7):e0133808. doi: 10.1371/journal.pone.0133808. eCollection 2015.


Single-Stranded DNA Aptamers against Pathogens and Toxins: Identification and Biosensing Applications.

Hong KL, Sooter LJ.

Biomed Res Int. 2015;2015:419318. doi: 10.1155/2015/419318. Epub 2015 Jun 23. Review.


Synthesis, structure, and antimicrobial activity of heterocyclic phenylsulfonyl- and 4-aminophenylsulfonyl-carboximidamides.

Gobis K, Foks H, Wiśniewska K, Dąbrowska-Szponar M, Augustynowicz-Kopeć E, Napiórkowska A, Sikorski A.

Monatsh Chem. 2012;143(8):1161-1169. Epub 2012 May 15.


Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance Escalation.

Ocheretina O, Shen L, Escuyer VE, Mabou MM, Royal-Mardi G, Collins SE, Pape JW, Fitzgerald DW.

PLoS One. 2015 Jun 3;10(6):e0129207. doi: 10.1371/journal.pone.0129207. eCollection 2015.


The impact of drug resistance on Mycobacterium tuberculosis physiology: what can we learn from rifampicin?

Koch A, Mizrahi V, Warner DF.

Emerg Microbes Infect. 2014 Mar;3(3):e17. doi: 10.1038/emi.2014.17. Epub 2014 Mar 12. Review.


Association between Multidrug-Resistant Tuberculosis and Risk Factors in China: Applying Partial Least Squares Path Modeling.

Liu YX, Pang CK, Liu Y, Sun XB, Li XX, Jiang SW, Xue F.

PLoS One. 2015 May 28;10(5):e0128298. doi: 10.1371/journal.pone.0128298. eCollection 2015.


Drug-resistance pattern of Mycobacterium tuberculosis strains from patients with pulmonary and extrapulmonary tuberculosis during 2006 to 2013 in a Korean tertiary medical center.

Lee HY, Lee J, Lee YS, Kim MY, Lee HK, Lee YM, Shin JH, Ko Y.

Korean J Intern Med. 2015 May;30(3):325-34. doi: 10.3904/kjim.2015.30.3.325. Epub 2015 Apr 29.


Pharmacokinetics of Second-Line Antituberculosis Drugs after Multiple Administrations in Healthy Volunteers.

Park SI, Oh J, Jang K, Yoon J, Moon SJ, Park JS, Lee JH, Song J, Jang IJ, Yu KS, Chung JY.

Antimicrob Agents Chemother. 2015 Aug;59(8):4429-35. doi: 10.1128/AAC.00354-15. Epub 2015 May 18.


Rapid Whole-Genome Sequencing of Mycobacterium tuberculosis Isolates Directly from Clinical Samples.

Brown AC, Bryant JM, Einer-Jensen K, Holdstock J, Houniet DT, Chan JZ, Depledge DP, Nikolayevskyy V, Broda A, Stone MJ, Christiansen MT, Williams R, McAndrew MB, Tutill H, Brown J, Melzer M, Rosmarin C, McHugh TD, Shorten RJ, Drobniewski F, Speight G, Breuer J.

J Clin Microbiol. 2015 Jul;53(7):2230-7. doi: 10.1128/JCM.00486-15. Epub 2015 May 13.


Correlations between drug resistance of Beijing/W lineage clinical isolates of Mycobacterium tuberculosis and sublineages: a 2009-2013 prospective study in Xinjiang province, China.

Wang XH, Ma AG, Han XX, Gu XM, Fu LP, Li PG, Li FY, Wang QZ, Liang H, Katar A, Wang LJ.

Med Sci Monit. 2015 May 7;21:1313-8. doi: 10.12659/MSM.892951.


The Mycobacterium tuberculosis ClpP1P2 Protease Interacts Asymmetrically with Its ATPase Partners ClpX and ClpC1.

Leodolter J, Warweg J, Weber-Ban E.

PLoS One. 2015 May 1;10(5):e0125345. doi: 10.1371/journal.pone.0125345. eCollection 2015.


Outcomes and use of therapeutic drug monitoring in multidrug-resistant tuberculosis patients treated in virginia, 2009-2014.

Heysell SK, Moore JL, Peloquin CA, Ashkin D, Houpt ER.

Tuberc Respir Dis (Seoul). 2015 Apr;78(2):78-84. doi: 10.4046/trd.2015.78.2.78. Epub 2015 Apr 2.


Human IL-32 expression protects mice against a hypervirulent strain of Mycobacterium tuberculosis.

Bai X, Shang S, Henao-Tamayo M, Basaraba RJ, Ovrutsky AR, Matsuda JL, Takeda K, Chan MM, Dakhama A, Kinney WH, Trostel J, Bai A, Honda JR, Achcar R, Hartney J, Joosten LA, Kim SH, Orme I, Dinarello CA, Ordway DJ, Chan ED.

Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):5111-6. doi: 10.1073/pnas.1424302112. Epub 2015 Mar 27.


Structural and functional studies of phosphoenolpyruvate carboxykinase from Mycobacterium tuberculosis.

Machová I, Snášel J, Dostál J, Brynda J, Fanfrlík J, Singh M, Tarábek J, Vaněk O, Bednárová L, Pichová I.

PLoS One. 2015 Mar 23;10(3):e0120682. doi: 10.1371/journal.pone.0120682. eCollection 2015.


IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection.

Tonby K, Ruhwald M, Kvale D, Dyrhol-Riise AM.

Sci Rep. 2015 Mar 18;5:9223. doi: 10.1038/srep09223.


Defining multidrug-resistant tuberculosis: correlating GenoType MTBDRplus assay results with minimum inhibitory concentrations.

Kambli P, Ajbani K, Sadani M, Nikam C, Shetty A, Udwadia Z, Georghiou SB, Rodwell TC, Catanzaro A, Rodrigues C.

Diagn Microbiol Infect Dis. 2015 May;82(1):49-53. doi: 10.1016/j.diagmicrobio.2015.01.009. Epub 2015 Jan 29.


Quantitative drug-susceptibility in patients treated for multidrug-resistant tuberculosis in Bangladesh: implications for regimen choice.

Heysell SK, Ahmed S, Ferdous SS, Khan MS, Rahman SM, Gratz J, Rahman MT, Mahmud AM, Houpt ER, Banu S.

PLoS One. 2015 Feb 24;10(2):e0116795. doi: 10.1371/journal.pone.0116795. eCollection 2015.


Draft Genome Sequence of an Extensively Drug-Resistant Mycobacterium tuberculosis Manu-Ancestor Spoligo-International Type 523 Isolate from Thailand.

Regmi SM, Chaiprasert A, Coker OO, Disratthakit A, Prammananan T, Suriyaphol P, Yik-Ying T, Twee Hee O.

Genome Announc. 2015 Feb 19;3(1). pii: e01589-14. doi: 10.1128/genomeA.01589-14.


Targeting Mycobacterium tuberculosis topoisomerase I by small-molecule inhibitors.

Godbole AA, Ahmed W, Bhat RS, Bradley EK, Ekins S, Nagaraja V.

Antimicrob Agents Chemother. 2015 Mar;59(3):1549-57. doi: 10.1128/AAC.04516-14. Epub 2014 Dec 22.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk